Concepts (205)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Atrial Fibrillation | 18 | 2019 | 313 | 4.340 |
Why?
|
Electrocardiography | 17 | 2019 | 568 | 2.070 |
Why?
|
Heart Conduction System | 6 | 2018 | 70 | 1.760 |
Why?
|
Catheter Ablation | 5 | 2017 | 62 | 1.470 |
Why?
|
Pacemaker, Artificial | 5 | 2019 | 17 | 1.220 |
Why?
|
Myocardial Infarction | 8 | 2017 | 418 | 1.160 |
Why?
|
Atrial Appendage | 2 | 2017 | 9 | 1.150 |
Why?
|
Cardiac Surgical Procedures | 2 | 2017 | 72 | 1.100 |
Why?
|
Postoperative Complications | 3 | 2015 | 634 | 1.000 |
Why?
|
Arrhythmias, Cardiac | 3 | 2014 | 81 | 0.940 |
Why?
|
Anticoagulants | 4 | 2017 | 119 | 0.890 |
Why?
|
Heart Failure | 4 | 2018 | 574 | 0.830 |
Why?
|
Humans | 45 | 2019 | 28304 | 0.740 |
Why?
|
Male | 37 | 2019 | 16967 | 0.730 |
Why?
|
Cardiac Pacing, Artificial | 2 | 2016 | 10 | 0.700 |
Why?
|
Environmental Pollution | 1 | 2018 | 4 | 0.690 |
Why?
|
Water Pollutants, Chemical | 1 | 2018 | 2 | 0.690 |
Why?
|
Mercury | 1 | 2018 | 7 | 0.690 |
Why?
|
Environmental Monitoring | 1 | 2018 | 26 | 0.680 |
Why?
|
Heart Ventricles | 4 | 2018 | 115 | 0.660 |
Why?
|
Hyperkalemia | 1 | 2018 | 11 | 0.660 |
Why?
|
Cardiac-Gated Imaging Techniques | 1 | 2017 | 14 | 0.650 |
Why?
|
Aortic Valve Insufficiency | 1 | 2017 | 24 | 0.640 |
Why?
|
Septal Occluder Device | 1 | 2017 | 4 | 0.620 |
Why?
|
Heart Valve Prosthesis | 1 | 2017 | 53 | 0.610 |
Why?
|
Intracranial Embolism | 1 | 2017 | 12 | 0.610 |
Why?
|
Female | 34 | 2019 | 17679 | 0.610 |
Why?
|
Denervation | 1 | 2017 | 11 | 0.610 |
Why?
|
Ventricular Premature Complexes | 1 | 2017 | 12 | 0.610 |
Why?
|
Middle Aged | 28 | 2018 | 10678 | 0.600 |
Why?
|
Electric Countershock | 2 | 2013 | 10 | 0.590 |
Why?
|
Stroke | 6 | 2017 | 443 | 0.580 |
Why?
|
Healthcare Disparities | 2 | 2015 | 148 | 0.570 |
Why?
|
Treatment Outcome | 13 | 2017 | 2886 | 0.560 |
Why?
|
Tomography, X-Ray Computed | 3 | 2017 | 858 | 0.550 |
Why?
|
Hospitalization | 4 | 2017 | 386 | 0.540 |
Why?
|
Defibrillators, Implantable | 4 | 2019 | 17 | 0.540 |
Why?
|
Retrospective Studies | 17 | 2019 | 2930 | 0.540 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2015 | 7 | 0.540 |
Why?
|
Thromboembolism | 1 | 2015 | 29 | 0.530 |
Why?
|
Tachycardia, Atrioventricular Nodal Reentry | 1 | 2014 | 3 | 0.530 |
Why?
|
Prostheses and Implants | 1 | 2015 | 39 | 0.530 |
Why?
|
Aged | 23 | 2019 | 9256 | 0.520 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2015 | 145 | 0.510 |
Why?
|
Risk Factors | 17 | 2019 | 3520 | 0.500 |
Why?
|
Coffee | 1 | 2013 | 10 | 0.480 |
Why?
|
Cheyne-Stokes Respiration | 1 | 2013 | 1 | 0.480 |
Why?
|
Caffeine | 1 | 2013 | 31 | 0.470 |
Why?
|
Cardiac Output, High | 1 | 2012 | 1 | 0.460 |
Why?
|
Iliac Vein | 1 | 2012 | 8 | 0.450 |
Why?
|
Arteriovenous Fistula | 1 | 2012 | 10 | 0.450 |
Why?
|
Respiration, Artificial | 1 | 2013 | 93 | 0.450 |
Why?
|
Iliac Artery | 1 | 2012 | 47 | 0.450 |
Why?
|
Warfarin | 3 | 2017 | 30 | 0.440 |
Why?
|
Early Diagnosis | 1 | 2011 | 60 | 0.420 |
Why?
|
Aged, 80 and over | 12 | 2017 | 3562 | 0.410 |
Why?
|
Angina Pectoris | 1 | 2011 | 19 | 0.410 |
Why?
|
Coronary Stenosis | 1 | 2011 | 29 | 0.410 |
Why?
|
Stents | 1 | 2011 | 131 | 0.380 |
Why?
|
Atrial Flutter | 3 | 2016 | 12 | 0.380 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 133 | 0.370 |
Why?
|
Chest Pain | 2 | 2011 | 175 | 0.360 |
Why?
|
United States | 11 | 2019 | 3588 | 0.360 |
Why?
|
Health Status | 1 | 2011 | 360 | 0.350 |
Why?
|
Surgical Procedures, Operative | 3 | 2014 | 74 | 0.350 |
Why?
|
European Continental Ancestry Group | 4 | 2019 | 1203 | 0.340 |
Why?
|
Keratitis | 1 | 2008 | 3 | 0.340 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2008 | 10 | 0.340 |
Why?
|
Pneumococcal Infections | 1 | 2008 | 26 | 0.330 |
Why?
|
Streptococcus pneumoniae | 1 | 2008 | 36 | 0.330 |
Why?
|
Incidence | 5 | 2019 | 1087 | 0.310 |
Why?
|
Medicare | 3 | 2019 | 181 | 0.310 |
Why?
|
Brain Ischemia | 2 | 2019 | 105 | 0.300 |
Why?
|
African Americans | 4 | 2019 | 1513 | 0.280 |
Why?
|
Diagnosis, Differential | 4 | 2014 | 478 | 0.260 |
Why?
|
Stroke Volume | 3 | 2018 | 278 | 0.250 |
Why?
|
Bundle-Branch Block | 2 | 2015 | 18 | 0.240 |
Why?
|
Sex Factors | 5 | 2017 | 619 | 0.240 |
Why?
|
HIV Infections | 1 | 2008 | 330 | 0.240 |
Why?
|
Multivariate Analysis | 6 | 2017 | 631 | 0.240 |
Why?
|
Confidence Intervals | 3 | 2012 | 136 | 0.230 |
Why?
|
Dyspnea | 2 | 2014 | 30 | 0.230 |
Why?
|
Patient Readmission | 2 | 2015 | 104 | 0.220 |
Why?
|
Age of Onset | 2 | 2013 | 98 | 0.220 |
Why?
|
Emergency Treatment | 2 | 2012 | 42 | 0.210 |
Why?
|
Cohort Studies | 4 | 2013 | 1673 | 0.200 |
Why?
|
Adult | 10 | 2017 | 8243 | 0.190 |
Why?
|
Proportional Hazards Models | 6 | 2017 | 706 | 0.180 |
Why?
|
Time Factors | 8 | 2017 | 1874 | 0.170 |
Why?
|
Cause of Death | 3 | 2018 | 219 | 0.170 |
Why?
|
Fossil Fuels | 1 | 2018 | 1 | 0.170 |
Why?
|
Mining | 1 | 2018 | 1 | 0.170 |
Why?
|
Rivers | 1 | 2018 | 2 | 0.170 |
Why?
|
Metals, Heavy | 1 | 2018 | 7 | 0.170 |
Why?
|
India | 1 | 2018 | 62 | 0.170 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2018 | 46 | 0.160 |
Why?
|
Pulmonary Veins | 1 | 2017 | 9 | 0.160 |
Why?
|
Follow-Up Studies | 4 | 2019 | 2027 | 0.150 |
Why?
|
Ventricular Function, Left | 1 | 2018 | 201 | 0.150 |
Why?
|
Cardiomyopathies | 1 | 2017 | 49 | 0.150 |
Why?
|
Odds Ratio | 3 | 2012 | 457 | 0.140 |
Why?
|
Echocardiography | 2 | 2018 | 142 | 0.140 |
Why?
|
Risk Assessment | 6 | 2019 | 1285 | 0.140 |
Why?
|
Brachiocephalic Veins | 1 | 2015 | 8 | 0.140 |
Why?
|
Prosthesis Implantation | 1 | 2015 | 35 | 0.140 |
Why?
|
Subclavian Vein | 1 | 2015 | 15 | 0.130 |
Why?
|
Heart Septum | 1 | 2015 | 2 | 0.130 |
Why?
|
Chi-Square Distribution | 4 | 2017 | 293 | 0.130 |
Why?
|
Dizziness | 1 | 2014 | 8 | 0.130 |
Why?
|
Health Status Disparities | 1 | 2016 | 105 | 0.130 |
Why?
|
Vascular Diseases | 1 | 2015 | 60 | 0.130 |
Why?
|
Hypertrophy, Left Ventricular | 2 | 2012 | 109 | 0.130 |
Why?
|
Coronary Angiography | 2 | 2012 | 140 | 0.120 |
Why?
|
Death, Sudden, Cardiac | 1 | 2014 | 57 | 0.120 |
Why?
|
Tachycardia, Paroxysmal | 1 | 2013 | 2 | 0.120 |
Why?
|
Tachycardia, Supraventricular | 1 | 2013 | 5 | 0.120 |
Why?
|
Ultrasonography | 2 | 2012 | 347 | 0.120 |
Why?
|
Arrhythmogenic Right Ventricular Dysplasia | 1 | 2012 | 1 | 0.110 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2012 | 3 | 0.110 |
Why?
|
Tachycardia, Ventricular | 1 | 2012 | 14 | 0.110 |
Why?
|
Edema | 1 | 2012 | 30 | 0.110 |
Why?
|
Kidney | 1 | 2017 | 495 | 0.110 |
Why?
|
Cardiomegaly | 1 | 2012 | 37 | 0.110 |
Why?
|
Erythema | 1 | 2012 | 27 | 0.110 |
Why?
|
Costs and Cost Analysis | 1 | 2012 | 84 | 0.110 |
Why?
|
Bacteremia | 1 | 2012 | 53 | 0.110 |
Why?
|
Aorta, Thoracic | 1 | 2012 | 73 | 0.110 |
Why?
|
Prosthesis Failure | 1 | 2012 | 42 | 0.110 |
Why?
|
Emergency Service, Hospital | 2 | 2012 | 419 | 0.110 |
Why?
|
Hispanic Americans | 2 | 2015 | 935 | 0.110 |
Why?
|
Thrombotic Microangiopathies | 1 | 2011 | 8 | 0.110 |
Why?
|
Physical Exertion | 1 | 2011 | 13 | 0.100 |
Why?
|
Radiography | 1 | 2012 | 339 | 0.100 |
Why?
|
Sympathomimetics | 1 | 2011 | 4 | 0.100 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2011 | 11 | 0.100 |
Why?
|
Methamphetamine | 1 | 2011 | 9 | 0.100 |
Why?
|
Pulmonary Embolism | 1 | 2011 | 46 | 0.100 |
Why?
|
Continental Population Groups | 1 | 2012 | 229 | 0.100 |
Why?
|
Perioperative Care | 1 | 2011 | 56 | 0.100 |
Why?
|
Predictive Value of Tests | 4 | 2016 | 774 | 0.100 |
Why?
|
Lymphoma, AIDS-Related | 1 | 2010 | 1 | 0.090 |
Why?
|
Health Services Accessibility | 1 | 2012 | 226 | 0.090 |
Why?
|
Heart Rupture | 1 | 2010 | 3 | 0.090 |
Why?
|
Lymphoma, T-Cell | 1 | 2010 | 5 | 0.090 |
Why?
|
Disease Progression | 1 | 2011 | 566 | 0.090 |
Why?
|
Young Adult | 2 | 2017 | 2321 | 0.090 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2009 | 52 | 0.080 |
Why?
|
Sensitivity and Specificity | 3 | 2015 | 521 | 0.080 |
Why?
|
Prognosis | 1 | 2011 | 1342 | 0.080 |
Why?
|
Propensity Score | 2 | 2017 | 34 | 0.080 |
Why?
|
Reproducibility of Results | 3 | 2015 | 700 | 0.080 |
Why?
|
Patient Admission | 2 | 2017 | 51 | 0.070 |
Why?
|
Administration, Oral | 2 | 2017 | 163 | 0.070 |
Why?
|
Depression | 1 | 2009 | 361 | 0.070 |
Why?
|
Databases, Factual | 2 | 2017 | 320 | 0.070 |
Why?
|
Anti-Bacterial Agents | 1 | 2008 | 283 | 0.070 |
Why?
|
Coronary Artery Disease | 1 | 2009 | 379 | 0.070 |
Why?
|
Prosthesis Design | 2 | 2015 | 87 | 0.060 |
Why?
|
Registries | 2 | 2012 | 269 | 0.050 |
Why?
|
Fatal Outcome | 2 | 2011 | 74 | 0.050 |
Why?
|
Severity of Illness Index | 2 | 2015 | 846 | 0.050 |
Why?
|
Medicare Part D | 1 | 2017 | 8 | 0.040 |
Why?
|
Comparative Effectiveness Research | 1 | 2017 | 23 | 0.040 |
Why?
|
Hemorrhage | 1 | 2017 | 86 | 0.040 |
Why?
|
Survival Rate | 1 | 2018 | 775 | 0.040 |
Why?
|
Iowa | 1 | 2015 | 9 | 0.030 |
Why?
|
Phlebography | 1 | 2015 | 18 | 0.030 |
Why?
|
Constriction, Pathologic | 1 | 2015 | 32 | 0.030 |
Why?
|
Ventricular Septum | 1 | 2015 | 1 | 0.030 |
Why?
|
Comorbidity | 1 | 2015 | 531 | 0.030 |
Why?
|
Observer Variation | 1 | 2013 | 96 | 0.030 |
Why?
|
California | 1 | 2013 | 61 | 0.030 |
Why?
|
Body Surface Potential Mapping | 1 | 2012 | 12 | 0.030 |
Why?
|
San Francisco | 1 | 2012 | 4 | 0.030 |
Why?
|
Urban Health Services | 1 | 2012 | 10 | 0.030 |
Why?
|
Cineradiography | 1 | 2012 | 1 | 0.030 |
Why?
|
Safety-Based Medical Device Withdrawals | 1 | 2012 | 1 | 0.030 |
Why?
|
Endocardium | 1 | 2012 | 3 | 0.030 |
Why?
|
Ambulances | 1 | 2012 | 12 | 0.030 |
Why?
|
ROC Curve | 1 | 2012 | 146 | 0.030 |
Why?
|
Troponin I | 1 | 2012 | 18 | 0.030 |
Why?
|
Telemedicine | 1 | 2013 | 72 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2012 | 25 | 0.030 |
Why?
|
Medical History Taking | 1 | 2012 | 32 | 0.030 |
Why?
|
Age Factors | 1 | 2015 | 1058 | 0.030 |
Why?
|
Device Removal | 1 | 2012 | 31 | 0.030 |
Why?
|
Running | 1 | 2011 | 16 | 0.030 |
Why?
|
Physicians | 1 | 2013 | 119 | 0.030 |
Why?
|
Substance-Related Disorders | 1 | 2012 | 82 | 0.030 |
Why?
|
Linear Models | 1 | 2012 | 421 | 0.030 |
Why?
|
Analysis of Variance | 1 | 2012 | 390 | 0.030 |
Why?
|
Research Design | 1 | 2012 | 271 | 0.020 |
Why?
|
Heart Atria | 1 | 2011 | 64 | 0.020 |
Why?
|
Emergency Medical Services | 1 | 2012 | 154 | 0.020 |
Why?
|
Logistic Models | 1 | 2012 | 727 | 0.020 |
Why?
|
Autopsy | 1 | 2010 | 37 | 0.020 |
Why?
|
Heart Arrest | 1 | 2010 | 39 | 0.020 |
Why?
|
Adolescent | 1 | 2017 | 3184 | 0.020 |
Why?
|
Prevalence | 1 | 2012 | 881 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2013 | 1345 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2010 | 189 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2011 | 299 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2011 | 374 | 0.020 |
Why?
|
Prospective Studies | 1 | 2012 | 1932 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2011 | 655 | 0.020 |
Why?
|